Omeros Corporation (3O8.F)
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
10.20+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+227.6%
The outlook
Omeros Corporation currently reads as leaning bullish based on above its 50- & 200-day averages, 58% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range58% of the way from its 52-week low to high
Market cap
$738.2M
52-wk high
15.46
52-wk low
2.96
50-day avg
8.77
200-day avg
9.34
Trailing P/E
10.2